The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA ...

Androgenic alopecia, commonly known as male or female pattern baldness, affects millions worldwide, offering few treatment ...

The FDA has granted accelerated approval to Datroway for adults with previously-treated, locally advanced or metastatic EGFR-mutated NSCLC.

Wondering about minoxidil 10% or higher for hair loss? When it comes to this topical product, a higher strength doesn’t ...

Meet the experts: Chesahna Kindred, MD, is a dermatologist in Marriottsville, Maryland, who specializes in hair loss. Melissa Piliang, MD, is a dermatologist and hair loss specialist at the Cleveland ...

The first pill to treat adults with severe alopecia was approved by the U.S. Food and Drug Administration on Monday. Olumiant (baricitinib) is the first FDA-approved alopecia therapy that treats the ...

An estimated 30 million women in the US are losing their hair. A top dermatologist explains the condition and lays out ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

Matthew Riccardi was just 11 years old when he was diagnosed with the same condition: alopecia areata, an autoimmune disorder ...

The U.S. Food and Drug Administration's approval of lenacapavir, a twice-a-year injectable medication that has been shown to prevent HIV infections leaves questions of access and cost largely ...

Dato-DXd was granted accelerated approval for use in adults with EGFR-mutated NSCLC after EGFR-targeted therapy and platinum-based chemotherapy.